文献速递冠心病血脂与心血管预防

高敏心肌肌钙蛋白用于慢性冠心病风险分层

High-Sensitivity Cardiac Troponin for Risk Assessment in Patients With Chronic Coronary Artery Disease.
PubMed 文献 · J Am Coll Cardiol · 2023-01-01

研究纳入4240例疑似稳定型心绞痛并接受门诊冠状动脉造影的患者,造影前盲法检测高敏心肌肌钙蛋白I。在3888例确诊冠心病患者中,随访中位2.4年发生255例主要终点事件;肌钙蛋白浓度与心梗或心血管死亡独立相关(校正HR 2.3,95%CI 1.7-3.0)。

要点

  • 慢性冠心病患者中,高敏肌钙蛋白可独立于传统危险因素和病变严重程度预测心梗或心血管死亡。
  • 肌钙蛋白>10 ng/L者心梗或心血管死亡风险增加50%。
  • 常规检测能否指导高危患者强化治疗尚需进一步研究。

核心结论

  • 在慢性冠心病患者中,心脏肌钙蛋白独立于心血管危险因素和疾病严重程度预测心肌梗死或心血管死亡风险。

研究设计与样本

  • 前瞻性队列研究,连续纳入因疑似稳定型心绞痛症状接受门诊冠状动脉造影的患者,造影前检测高敏心肌肌钙蛋白I且临床医生对结果设盲。
  • 共4240例患者,年龄66岁(IQR 59-73),女性33%;3888例(92%)检出冠心病。

主要发现

  • 冠心病患者中,发生事件者肌钙蛋白浓度为6.7 ng/L(IQR 3.2-14.2),未发生事件者为3.3 ng/L(IQR 1.7-6.6),P<0.001。
  • 校正心血管危险因素和冠状动脉疾病严重程度后,肌钙蛋白与主要终点相关(校正HR 2.3;95%CI 1.7-3.0,log10肌钙蛋白;P<0.001)。
  • 肌钙蛋白浓度>10 ng/L的患者心肌梗死或心血管死亡风险增加50%。
  • 中位随访2.4年(IQR 1.3-3.6)期间,冠心病患者中共发生255例(6%)主要终点事件。

临床怎么用

  • 对慢性冠心病患者,可考虑检测高敏心肌肌钙蛋白以辅助识别心梗或心血管死亡高危者。
  • 肌钙蛋白>10 ng/L提示风险增加50%,但常规检测能否指导治疗强化尚需进一步研究。

局限性

  • 研究为观察性队列,尚需进一步研究评估常规检测能否用于选择高危患者进行强化治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cardiac troponin is used for risk stratification of patients with acute coronary syndromes; however, the role of testing in other settings remains unclear. OBJECTIVES: The aim of this study was to evaluate whether cardiac troponin testing could enhance risk stratification in patients with chronic coronary artery disease independent of disease severity and conventional risk measures. METHODS: In a prospective cohort of consecutive patients with symptoms suggestive of stable angina attending for outpatient coronary angiography, high-sensitivity cardiac troponin I was measured before angiography, and clinicians were blinded to the results. The primary outcome was myocardial infarction or cardiovascular death during follow-up. RESULTS: In 4,240 patients (age 66 years [IQR: 59-73 years], 33% female), coronary artery disease was identified in 3,888 (92%) who had 255 (6%) primary outcome events during a median follow-up of 2.4 years (IQR: 1.3-3.6 years). In patients with coronary artery disease, troponin concentrations were 2-fold higher in those with an event compared with those without (6.7 ng/L [IQR: 3.2-14.2 ng/L] vs 3.3 ng/L [IQR: 1.7-6.6 ng/L]; P < 0.001). Troponin concentrations were associated with the primary outcome after adjusting for cardiovascular risk factors and coronary artery disease severity (adjusted HR: 2.3; 95% CI: 1.7-3.0, log10 troponin; P < 0.001). A troponin concentration >10 ng/L identified patients with a 50% increase in the risk of myocardial infarction or cardiovascular death. CONCLUSIONS: In patients with chronic coronary artery disease, cardiac troponin predicts risk of myocardial infarction or cardiovascular death independent of cardiovascular risk factors and disease severity. Further studies are required to evaluate whether routine testing could inform the selection of high-risk patients for treatment intensification. (Myocardial Injury in Patients Referred for Coronary Angiography [MICA]; ISRCTN15620297).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Wereski R, Adamson P, Shek Daud NS, et al. High-Sensitivity Cardiac Troponin for Risk Assessment in Patients With Chronic Coronary Artery Disease. J Am Coll Cardiol. 2023. PMID: 37532417. doi:10.1016/j.jacc.2023.05.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。